NCT01116141View on ClinicalTrials.gov

A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA)

PHASE2CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

May 31, 2012

Conditions
Rheumatoid Arthritis
Interventions
DRUG

CH-4051

Different doses CH-4051 to be compared

DRUG

Methotrexate (MTX)

20 mg MTX weekly

DRUG

Folic Acid

1 mg folic acid daily

Sponsors
All Listed Sponsors
lead

Chelsea Therapeutics

INDUSTRY